
Doctors Pharmaceuticals Private Limited
About Doctors Pharmaceuticals Private Limited
Data last updated:
Doctors Pharmaceuticals Private Limited is a private limited company based in Unnao, Uttar Pradesh, India. It operates in the alternative and holistic medicine segment of the healthcare sector. It was incorporated on 19 April 1976 and has been in existence for over 50 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U85110UP1976PTC004263. Its GSTIN is 09AABCD8614M1ZB (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4.5 Lakh. It is led by directors including Nikhil Chandak (Managing Director) and Krishna Gopal Srivastava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 35 Industrial Estae Akrampur, Unnao, Uttar Pradesh, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.03 Lakh, a decline of 14% compared to the previous year. For the same year it recorded a net profit of ₹925 (net margin 0.1%) and EBITDA of ₹28,373 (EBITDA margin 2.2%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years and 13% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Doctors Pharmaceuticals Private Limited's registered office is in Unnao, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address35 Industrial Estae Akrampur, Unnao, Uttar Pradesh, India
- IndustryHealthcare, Alternative & Holistic Medicine
To see the full contact details of Doctors Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Doctors Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Doctors Pharmaceuticals Private Limited, buy the company report.
Financials of Doctors Pharmaceuticals Private Limited
FY 2025 filings availableDoctors Pharmaceuticals Private Limited reported revenue of ₹13.03 Lakh (down 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 13% over five years, including a 14% fall in the latest year. EBITDA rose 43% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹28,373 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹925 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.2% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Doctors Pharmaceuticals Private Limited, buy the company report.
Board of directors of Doctors Pharmaceuticals Private Limited
Doctors Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krishna Gopal Srivastava | Director | 29 Sep 1997 | 29 Years 1 Months | Current |
| Anila Chandak | Director | 01 Jun 2022 | 4 Years 5 Months | Current |
| Nikhil Chandak | Managing Director | 23 Mar 2013 | 13 Years 7 Months | Current |
Peer comparison
Doctors Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Alternative Medicine, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Konniseri Pharmaceuticals Private Limited | ₹13.07 Lakh (FY 2019) | 1041.0% | Bangalore, Karnataka, India | |||
| Doctors Pharmaceuticals Private Limitedthis company | ₹13.03 Lakh (FY 2025) | ₹925 | 0.1% | -14.0% | Unnao, Uttar Pradesh, India | |
| Aavn Pharmaceuticals (OPC) Private Limited | ₹12.92 Lakh (FY 2025) | -18.0% | Secunderabad, Telangana, India | |||
| Valmicare Pharmaceuticals Private Limited | ₹12.91 Lakh (FY 2019) | -54.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Doctors Pharmaceuticals Private Limited, buy the company report.
Auditor
Doctors Pharmaceuticals Private Limited is audited by BATRA AGRAWAL ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BATRA AGRAWAL ASSOCIATES | FY 2021 | 002522C |
Shareholding
The shareholding of Doctors Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Doctors Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Doctors Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Doctors Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Doctors Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AABCD8614M1ZB | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Doctors Pharmaceuticals Private Limited, buy the company report.
Recent activity
Doctors Pharmaceuticals Private Limited has 7 board changes on record since 1997: 3 appointments and 4 cessations. The latest: Anila Chandak was appointed as Director on 01 Jun 2022.
Frequently asked questions
Doctors Pharmaceuticals is an active private limited company based in Unnao, Uttar Pradesh, India. The company works in alternative and holistic medicine, within the healthcare industry. It was incorporated on 19 April 1976 (50+ years old) and is registered under CIN U85110UP1976PTC004263.
Doctors Pharmaceuticals has 3 current directors:
- Nikhil Chandak - Managing Director
- Krishna Gopal Srivastava - Director
- Anila Chandak - Director
The latest financial statements of Doctors Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Doctors Pharmaceuticals is 09AABCD8614M1ZB, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Doctors Pharmaceuticals is U85110UP1976PTC004263. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Doctors Pharmaceuticals was incorporated on 19 April 1976, making it 50+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Doctors Pharmaceuticals by revenue are Konniseri Pharmaceuticals Private Limited, Aavn Pharmaceuticals (OPC) Private Limited, Valmicare Pharmaceuticals Private Limited, all in the Healthcare industry (Alternative Medicine, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Anila Chandak was appointed as Director on 01 Jun 2022. Ratna Chandak ceased to be Director on 06 May 2021. Balkishan Makhanlal Chandak ceased to be Director on 27 Jan 2016. Doctors Pharmaceuticals has 7 board changes on record in total.
The registered office of Doctors Pharmaceuticals is at 35 Industrial Estae Akrampur, Unnao, Uttar Pradesh, India.
Doctors Pharmaceuticals operates in the healthcare industry, in the alternative and holistic medicine segment.
The compliance status of Doctors Pharmaceuticals is compliant as of 22 August 2026. The company is actively filing with the Registrar of Companies.

